One Stop Shop for All Your Market Research Reports

Global Tetanus Vaccine Market Professional Survey Report 2018

This report studies the global Tetanus Vaccine market status and forecast, categorizes the global Tetanus Vaccine market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). Tetanus vaccine, also known as tetanus toxoid (TT), is an inactive vaccine used to prevent tetanus. During childhood five doses are recommended, with a sixth given during adolescence. Additional doses every 10 years are recommended. After three doses almost everyone is initially immune. In those who are not up to date on their tetanus immunization a booster should be given within 48 hours of an injury. In those with high risk injuries who are not fully immunized tetanus antitoxin may also be recommended. Making sure women who are pregnant are up to date on their tetanus immunization and, if not, immunizing them can prevent neonatal tetanus. The vaccine is very safe including during pregnancy and in those with HIV/AIDS. Redness and pain at the site of injection occur in between 25% and 85% of people. Fever, feeling tired, and minor muscles pains occur in less than 10% of people. Severe allergic reactions occur in less than one in 100,000 people. A number of vaccine combinations include the tetanus vaccine such as DTaP and Tdap which contain diphtheria, tetanus, and pertussis vaccine, and DT and Td which contain diphtheria and tetanus vaccine. DTaP and DT are given to children less than seven years old while Tdap and Td are given to those seven years old and older. The lowercase d and p denote lower strengths of diphtheria and pertussis vaccines. The tetanus vaccine was developed in 1924 and became available in the United States in the 1940s. Its use resulted in a 95% decrease in the rate of tetanus. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between 0.17 and 0.65 USD per dose as of 2014.In the United States a course of tetanus vaccine is between 25 and 50 USD. The global Tetanus Vaccine market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The major manufacturers covered in this report GlaxoSmithKline plc Pfizer,Inc Merck & Co.,Inc Sanofi Pasteur SA Biological E Dano Vaccine &Biological Pvt.Ltd., Panera Shantha Biotechnics Ltd ... Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering North America Europe China Japan India Southeast Asia Other regions (Central & South America, Middle East & Africa) We can also provide the customized separate regional or country-level reports, for the following regions: North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Rest of Asia-Pacific Europe Germany France UK Italy Spain Russia Rest of Europe Central & South America Brazil Argentina Rest of South America Middle East & Africa Saudi Arabia Turkey Rest of Middle East & Africa On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Diphtheria and tetanus (DT) vaccines Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines Tetanus and diphtheria (Td) vaccines Tetanus, diphtheria, and pertussis (Tdap) vaccines By Application, the market can be split into Adult Pediatric The study objectives of this report are: To analyze and study the global Tetanus Vaccine capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025); Focuses on the key Tetanus Vaccine manufacturers, to study the capacity, production, value, market share and development plans in future. Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis. To define, describe and forecast the market by type, application and region. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. To identify significant trends and factors driving or inhibiting the market growth. To analyze the opportunities in the market for stakeholders by identifying the high growth segments. To strategically analyze each submarket with respect to individual growth trend and their contribution to the market. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Tetanus Vaccine are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered. Key Stakeholders Tetanus Vaccine Manufacturers Tetanus Vaccine Distributors/Traders/Wholesalers Tetanus Vaccine Subcomponent Manufacturers Industry Association Downstream Vendors Available Customizations With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report: Regional and country-level analysis of the Tetanus Vaccine market, by end-use. Detailed analysis and profiles of additional market players.
Table of Contents Global Tetanus Vaccine Market Professional Survey Report 2018 1 Industry Overview of Tetanus Vaccine 1.1 Definition and Specifications of Tetanus Vaccine 1.1.1 Definition of Tetanus Vaccine 1.1.2 Specifications of Tetanus Vaccine 1.2 Classification of Tetanus Vaccine 1.2.1 Diphtheria and tetanus (DT) vaccines 1.2.2 Diphtheria, tet
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3500
Corporate User US $7000
About this Report
Report ID 249234
Category
  • Pharmaceuticals and Healthcare
Published on 09-Aug
Number of Pages 107
Publisher Name QY Research
Editor Rating
★★★★★
★★★★★
(30)